(+)-pilocarpine increases expression ISO RGD:2559 6480464 Pilocarpine results in increased expression of EPO mRNA CTD PMID:17166730 (R)-noradrenaline decreases response to substance ISO RGD:10531 6480464 EPO protein results in decreased susceptibility to Norepinephrine CTD PMID:14732207 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of EPO mRNA CTD PMID:18247414 1-octadec-9-enoylglycero-3-phosphate multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] more ... CTD PMID:21915944 1H-indole multiple interactions ISO RGD:2559 6480464 indole inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA], indole inhibits the reaction [cobaltous chloride results in increased expression of EPO protein] CTD PMID:21863063 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of EPO mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol multiple interactions ISO RGD:2559 6480464 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of EPO protein], 2-Methoxyestradiol promotes the reaction [Methylmercury Compounds results in decreased expression of EPO protein] CTD PMID:31850806 , PMID:32461003 2-methoxy-17beta-estradiol decreases expression ISO RGD:2559 6480464 2-Methoxyestradiol results in decreased expression of EPO protein CTD PMID:31850806 , PMID:32461003 2-naphthylamine increases expression EXP 6480464 2-Naphthylamine results in increased expression of EPO mRNA CTD PMID:18247414 3',5'-cyclic AMP increases expression ISO RGD:2559 6480464 Cyclic AMP results in increased expression of EPO protein CTD PMID:18621143 3',5'-cyclic GMP multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [GCH1 gene mutant form results in increased abundance of Cyclic GMP], EPO protein inhibits the reaction [HPH1 gene mutant form results in decreased abundance of Cyclic GMP] CTD PMID:25041251 , PMID:25490417 3,4-dihydroxybenzoic acid increases expression ISO RGD:2559 6480464 protocatechuic acid results in increased expression of EPO protein CTD PMID:31850806 , PMID:32461003 3,4-dihydroxybenzoic acid multiple interactions ISO RGD:2559 6480464 protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein], protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of EPO protein] CTD PMID:31850806 , PMID:32461003 5,6,7,8-tetrahydrobiopterin multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [[GCH1 gene mutant form results in increased oxidation of sapropterin] which results in increased chemical synthesis of 7 more ... CTD PMID:25041251 , PMID:25490417 5,6,7,8-tetrahydrobiopterin multiple interactions EXP 6480464 EPO protein inhibits the reaction [GCH1 mutant form results in decreased abundance of sapropterin] CTD PMID:25041251 5,6,7,8-tetrahydrobiopterin increases abundance ISO RGD:10531 6480464 EPO protein results in increased abundance of sapropterin CTD PMID:25490417 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of EPO mRNA CTD PMID:19194470 5-chloro-7-iodoquinolin-8-ol increases expression EXP 6480464 Clioquinol results in increased expression of EPO mRNA CTD PMID:16973622 5-chloro-7-iodoquinolin-8-ol decreases expression EXP 6480464 Clioquinol results in decreased expression of EPO mRNA CTD PMID:19502547 5-fluorouracil increases response to substance EXP 6480464 EPO protein results in increased susceptibility to Fluorouracil CTD PMID:16103069 5-fluorouracil increases expression ISO RGD:2559 6480464 Fluorouracil results in increased expression of EPO protein CTD PMID:20020992 , PMID:2206997 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:19502547 acetylcholine multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [GCH1 gene mutant form results in decreased susceptibility to Acetylcholine] CTD PMID:25490417 acetylcholine increases response to substance ISO RGD:10531 6480464 EPO protein results in increased susceptibility to Acetylcholine CTD PMID:25490417 Actein decreases expression ISO RGD:2559 6480464 actein results in decreased expression of EPO mRNA CTD PMID:19527300 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of EPO mRNA CTD PMID:21641981 , PMID:22100608 aldehydo-D-glucose multiple interactions EXP 6480464 [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA more ... CTD PMID:30894315 all-trans-retinoic acid increases expression ISO RGD:2559 6480464 Tretinoin results in increased expression of EPO mRNA CTD PMID:20488242 all-trans-retinol increases expression EXP 6480464 Vitamin A results in increased expression of EPO protein CTD PMID:16960172 all-trans-retinol increases expression ISO RGD:2559 6480464 Vitamin A results in increased expression of EPO protein CTD PMID:9927288 all-trans-retinol multiple interactions ISO RGD:2559 6480464 Vitamin A inhibits the reaction [Hydrogen Peroxide results in decreased expression of EPO protein] CTD PMID:9927288 amitrole multiple interactions EXP 6480464 [Amitrole results in increased abundance of Hydrogen Peroxide] which results in decreased expression of EPO protein CTD PMID:7980410 ammonium chloride affects expression ISO RGD:2559 6480464 Ammonium Chloride affects the expression of EPO mRNA CTD PMID:16483693 amphotericin B multiple interactions EXP 6480464 Amphotericin B inhibits the reaction [[HIF1A protein binds to ARNT protein] which binds to EPO enhancer], Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:16189267 amphotericin B decreases expression EXP 6480464 Amphotericin B results in decreased expression of EPO protein CTD PMID:2299214 , PMID:697352 amphotericin B multiple interactions ISO RGD:2559 6480464 Amphotericin B inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:16189267 benzene multiple interactions ISO RGD:10531 6480464 Benzene inhibits the reaction [Formaldehyde results in increased expression of EPO mRNA] CTD PMID:28373009 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of EPO mRNA CTD PMID:18247414 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of EPO 3' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation EXP 6480464 Benzoapyrene affects the methylation of EPO promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of EPO mRNA CTD PMID:22316170 bisphenol A multiple interactions EXP 6480464 bisphenol A inhibits the reaction [Cobalt results in increased expression of EPO mRNA], bisphenol A inhibits the reaction [HIF1A protein results in increased expression of EPO mRNA] CTD PMID:15147973 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EPO mRNA CTD PMID:30903817 BQ 123 multiple interactions ISO RGD:2559 6480464 cycloTrp-Asp-Pro-Val-Leu promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:24557580 cadmium atom multiple interactions EXP 6480464 Cadmium inhibits the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EPO promoter]], Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:10866824 cadmium dichloride decreases expression ISO RGD:2559 6480464 Cadmium Chloride results in decreased expression of EPO protein CTD PMID:21540277 cadmium dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA] more ... CTD PMID:11090055 cadmium dichloride decreases methylation ISO RGD:2559 6480464 Cadmium Chloride results in decreased methylation of EPO promoter CTD PMID:22457795 calycosin increases expression EXP 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone results in increased expression of EPO mRNA CTD PMID:21309574 calycosin-7-O-beta-D-glucoside increases expression EXP 6480464 calycosin-7-O-beta-D-glucoside results in increased expression of EPO mRNA CTD PMID:21309574 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of EPO mRNA CTD PMID:24752500 carbon monoxide increases expression ISO RGD:2559 6480464 Carbon Monoxide results in increased expression of EPO mRNA, Carbon Monoxide results in increased expression of EPO protein CTD PMID:9263988 carboplatin increases expression ISO RGD:2559 6480464 Carboplatin results in increased expression of EPO protein CTD PMID:17891399 ceftriaxone increases expression ISO RGD:2559 6480464 Ceftriaxone results in increased expression of EPO mRNA CTD PMID:29745864 cisplatin increases expression ISO RGD:2559 6480464 Cisplatin results in increased expression of EPO protein CTD PMID:2206997 cisplatin increases response to substance EXP 6480464 EPO protein results in increased susceptibility to Cisplatin CTD PMID:23077460 cisplatin decreases response to substance EXP 6480464 EPO protein results in decreased susceptibility to Cisplatin CTD PMID:23077460 cisplatin multiple interactions EXP 6480464 Cisplatin inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA] more ... CTD PMID:11090055 , PMID:22013135 cisplatin affects expression ISO RGD:2559 6480464 Cisplatin affects the expression of EPO protein CTD PMID:20020992 cisplatin decreases response to substance ISO RGD:2559 6480464 EPO protein results in decreased susceptibility to Cisplatin CTD PMID:20722073 cobalt atom multiple interactions EXP 6480464 bisphenol A inhibits the reaction [Cobalt results in increased expression of EPO mRNA] CTD PMID:15147973 cobalt atom increases expression ISO RGD:2559 6480464 Cobalt results in increased expression of EPO mRNA, Cobalt results in increased expression of EPO protein CTD PMID:17967803 , PMID:23877121 cobalt atom multiple interactions ISO RGD:2559 6480464 Diethylstilbestrol inhibits the reaction [Cobalt results in increased expression of EPO mRNA], Diethylstilbestrol inhibits the reaction [Cobalt results in increased expression of EPO protein] CTD PMID:23877121 cobalt atom increases expression EXP 6480464 Cobalt results in increased expression of EPO mRNA CTD PMID:10699462 more ... cobalt dichloride multiple interactions EXP 6480464 Cadmium Chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA] more ... CTD PMID:11090055 more ... cobalt dichloride increases expression ISO RGD:10531 6480464 cobaltous chloride results in increased expression of EPO mRNA, cobaltous chloride results in increased expression of EPO protein CTD PMID:10756076 , PMID:16772336 cobalt dichloride multiple interactions ISO RGD:2559 6480464 [cobaltous chloride results in increased expression of and results in increased activity of HIF1A protein] which results in increased expression of EPO protein more ... CTD PMID:18331222 more ... cobalt dichloride affects expression EXP 6480464 cobaltous chloride affects the expression of EPO protein CTD PMID:15743794 cobalt dichloride increases expression ISO RGD:2559 6480464 cobaltous chloride deficiency results in increased expression of EPO protein more ... CTD PMID:12819242 more ... cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of EPO mRNA, cobaltous chloride results in increased expression of EPO protein CTD PMID:11090055 more ... copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of EPO mRNA CTD PMID:19549813 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of EPO protein CTD PMID:10694834 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of EPO mRNA CTD PMID:16880289 cycloheximide multiple interactions ISO RGD:10531 6480464 Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:10756076 cyclophosphamide multiple interactions ISO RGD:2559 6480464 angelicae sinensis extract inhibits the reaction [Cyclophosphamide results in decreased expression of EPO mRNA], Astragali compound inhibits the reaction [Cyclophosphamide results in decreased expression of EPO mRNA] CTD PMID:19627214 cyclophosphamide increases response to substance ISO RGD:2559 6480464 EPO protein results in increased susceptibility to Cyclophosphamide CTD PMID:11245434 cyclophosphamide decreases expression ISO RGD:2559 6480464 Cyclophosphamide results in decreased expression of EPO mRNA CTD PMID:19627214 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of EPO mRNA CTD PMID:20106945 , PMID:25562108 cytochalasin B multiple interactions EXP 6480464 [Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein more ... CTD PMID:18776917 D-glucose multiple interactions EXP 6480464 [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA more ... CTD PMID:30894315 dacarbazine decreases response to substance EXP 6480464 EPO protein results in decreased susceptibility to Dacarbazine CTD PMID:15743794 decabromodiphenyl ether increases expression ISO RGD:2559 6480464 decabromobiphenyl ether results in increased expression of EPO mRNA CTD PMID:23914054 dehydroepiandrosterone multiple interactions EXP 6480464 [Dehydroepiandrosterone co-treated with Testosterone co-treated with GH1] results in decreased expression of EPO protein CTD PMID:15161484 desferrioxamine B increases expression EXP 6480464 Deferoxamine results in increased expression of EPO mRNA CTD PMID:10699462 desferrioxamine B increases expression ISO RGD:10531 6480464 Deferoxamine deficiency results in increased expression of EPO mRNA, Deferoxamine results in increased expression of EPO mRNA CTD PMID:10756076 desferrioxamine B increases stability ISO RGD:10531 6480464 Deferoxamine deficiency results in increased stability of EPO mRNA CTD PMID:10756076 desferrioxamine B increases expression ISO RGD:2559 6480464 Deferoxamine results in increased expression of EPO mRNA, Deferoxamine results in increased expression of EPO protein CTD PMID:10559391 more ... desferrioxamine B multiple interactions ISO RGD:2559 6480464 Deferoxamine inhibits the reaction [Reactive Oxygen Species results in decreased expression of EPO protein] CTD PMID:9927288 dexamethasone multiple interactions EXP 6480464 Dexamethasone analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 diclofenac affects expression EXP 6480464 Diclofenac affects the expression of EPO mRNA CTD PMID:24752500 diethylstilbestrol multiple interactions ISO RGD:2559 6480464 Diethylstilbestrol inhibits the reaction [Cobalt results in increased expression of EPO mRNA] more ... CTD PMID:23877121 Dihydrotanshinone I multiple interactions EXP 6480464 dihydrotanshinone I inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:26282490 dioxygen multiple interactions EXP 6480464 3-5'-hydroxymethyl-2'-furyl-1-benzylindazole inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] more ... CTD PMID:10866824 more ... dioxygen increases secretion EXP 6480464 Oxygen deficiency results in increased secretion of EPO protein CTD PMID:23958427 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of EPO mRNA, Oxygen deficiency results in increased expression of EPO protein CTD PMID:10866824 more ... dioxygen increases expression ISO RGD:10531 6480464 Oxygen deficiency results in increased expression of EPO mRNA CTD PMID:10756076 more ... dioxygen multiple interactions ISO RGD:10531 6480464 Cycloheximide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA], Hydrogen Peroxide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:10756076 dioxygen increases expression ISO RGD:2559 6480464 Oxygen deficiency results in increased expression of EPO more ... CTD PMID:18331222 more ... dioxygen multiple interactions ISO RGD:2559 6480464 [Oxygen deficiency co-treated with cobaltous chloride] results in increased expression of EPO mRNA more ... CTD PMID:16189267 more ... doxorubicin multiple interactions ISO RGD:10531 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] more ... CTD PMID:16449733 , PMID:17928571 doxorubicin increases response to substance ISO RGD:2559 6480464 EPO protein results in increased susceptibility to Doxorubicin CTD PMID:17924179 doxorubicin increases response to substance ISO RGD:10531 6480464 EPO protein results in increased susceptibility to Doxorubicin CTD PMID:17928571 doxorubicin multiple interactions ISO RGD:2559 6480464 EPO protein inhibits the reaction [Doxorubicin results in decreased abundance of Glutathione] more ... CTD PMID:16405037 more ... EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor decreases expression EXP 6480464 Angiotensin-Converting Enzyme Inhibitors results in decreased expression of EPO protein CTD PMID:2474097 enalapril decreases expression EXP 6480464 Enalapril results in decreased expression of EPO protein CTD PMID:2474097 , PMID:9434678 enalapril multiple interactions ISO RGD:2559 6480464 Enalapril inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] CTD PMID:19958114 etoposide multiple interactions EXP 6480464 EPO protein results in increased susceptibility to [Organoplatinum Compounds co-treated with Etoposide] CTD PMID:18403296 fenoterol increases expression EXP 6480464 Fenoterol results in increased expression of EPO protein CTD PMID:9209250 formaldehyde multiple interactions ISO RGD:10531 6480464 Benzene inhibits the reaction [Formaldehyde results in increased expression of EPO mRNA] CTD PMID:28373009 formaldehyde increases expression ISO RGD:10531 6480464 Formaldehyde results in increased expression of EPO mRNA CTD PMID:28373009 formononetin increases expression EXP 6480464 formononetin results in increased expression of EPO mRNA CTD PMID:21309574 gentamycin decreases expression ISO RGD:2559 6480464 Gentamicins results in decreased expression of EPO protein CTD PMID:1982298 gentamycin decreases response to substance ISO RGD:2559 6480464 EPO protein results in decreased susceptibility to Gentamicins CTD PMID:16467726 glucose multiple interactions EXP 6480464 [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA more ... CTD PMID:30894315 glutathione multiple interactions ISO RGD:2559 6480464 EPO protein inhibits the reaction [Doxorubicin results in decreased abundance of Glutathione] CTD PMID:16405037 glutathione multiple interactions EXP 6480464 EPO protein inhibits the reaction [Cisplatin results in decreased abundance of Glutathione] CTD PMID:22013135 haloperidol multiple interactions ISO RGD:2559 6480464 EPO protein inhibits the reaction [Haloperidol results in decreased expression of BCL2L1 protein] more ... CTD PMID:17805306 hydrogen peroxide multiple interactions EXP 6480464 [Amitrole results in increased abundance of Hydrogen Peroxide] which results in decreased expression of EPO protein more ... CTD PMID:7980410 hydrogen peroxide multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [GCH1 gene mutant form results in increased abundance of Hydrogen Peroxide], Hydrogen Peroxide inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:10756076 , PMID:25490417 hydrogen peroxide multiple interactions ISO RGD:2559 6480464 Vitamin A inhibits the reaction [Hydrogen Peroxide results in decreased expression of EPO protein] CTD PMID:9927288 hydrogen peroxide decreases expression ISO RGD:2559 6480464 Hydrogen Peroxide results in decreased expression of EPO protein CTD PMID:9927288 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of EPO protein CTD PMID:7980410 hydroxyurea increases expression EXP 6480464 Hydroxyurea results in increased expression of EPO protein CTD PMID:19724057 indometacin multiple interactions ISO RGD:2559 6480464 EPO protein inhibits the reaction [Indomethacin results in increased activity of MPO protein] CTD PMID:20723003 indoxyl sulfate multiple interactions EXP 6480464 Indican inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA], Indican inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:21863063 iron atom affects response to substance EXP 6480464 Iron affects the susceptibility to EPO protein CTD PMID:24806658 iron(0) affects response to substance EXP 6480464 Iron affects the susceptibility to EPO protein CTD PMID:24806658 iron(III) citrate increases expression EXP 6480464 ferric citrate results in increased expression of EPO mRNA CTD PMID:29959986 kainic acid multiple interactions EXP 6480464 EPO protein inhibits the reaction [Kainic Acid results in decreased expression of EPOR protein] more ... CTD PMID:18711747 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein promotes the reaction [Oxygen deficiency results in increased expression of EPO mRNA]], Ketoconazole inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:21566342 L-erythro-7,8-dihydrobiopterin multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [[GCH1 gene mutant form results in increased oxidation of sapropterin] which results in increased chemical synthesis of 7 more ... CTD PMID:25041251 , PMID:25490417 lipopolysaccharide multiple interactions ISO RGD:10531 6480464 [Lipopolysaccharides co-treated with EPO protein] results in increased expression of BCL2L1 protein more ... CTD PMID:24561306 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein], 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein results in increased abundance of Nitrites] CTD PMID:21915944 , PMID:23384249 LY294002 multiple interactions ISO RGD:10531 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] more ... CTD PMID:17928571 LY294002 multiple interactions ISO RGD:2559 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein results in decreased susceptibility to Levodopa], 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO results in increased phosphorylation of GSK3B protein] CTD PMID:17952604 , PMID:21683736 malonaldehyde decreases abundance EXP 6480464 EPO protein results in decreased abundance of Malondialdehyde CTD PMID:22013135 manganese atom increases glycosylation EXP 6480464 Manganese results in increased glycosylation of EPO protein CTD PMID:16937399 manganese(0) increases glycosylation EXP 6480464 Manganese results in increased glycosylation of EPO protein CTD PMID:16937399 menadione multiple interactions EXP 6480464 [Vitamin K 3 results in increased abundance of Hydrogen Peroxide] which results in decreased expression of EPO protein CTD PMID:7980410 mercury dichloride multiple interactions EXP 6480464 Mercuric Chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA] more ... CTD PMID:11090055 methylmercury chloride decreases expression ISO RGD:2559 6480464 methylmercuric chloride results in decreased expression of EPO protein CTD PMID:31850806 methylmercury chloride multiple interactions ISO RGD:2559 6480464 2-Methoxyestradiol promotes the reaction [methylmercuric chloride results in decreased expression of EPO protein] more ... CTD PMID:31850806 microcystin-LR decreases expression ISO RGD:10531 6480464 cyanoginosin LR results in decreased expression of EPO mRNA, cyanoginosin LR results in decreased expression of EPO protein CTD PMID:23454832 monosodium L-glutamate multiple interactions EXP 6480464 [EPO protein co-treated with Sodium Glutamate] affects the expression of CSF2RB mRNA more ... CTD PMID:30837834 monosodium L-glutamate affects expression ISO RGD:2559 6480464 Sodium Glutamate affects the expression of EPO protein CTD PMID:30837834 monosodium L-glutamate increases expression ISO RGD:2559 6480464 Sodium Glutamate results in increased expression of EPO mRNA CTD PMID:30837834 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:2559 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Methylmercury Compounds results in decreased expression of EPO protein] CTD PMID:31850806 , PMID:32461003 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:2559 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of EPO protein CTD PMID:31850806 , PMID:32461003 neopterin multiple interactions ISO RGD:10531 6480464 EPO protein promotes the reaction [GCH1 protein results in increased chemical synthesis of Neopterin] CTD PMID:25490417 nicotine increases expression EXP 6480464 Nicotine results in increased expression of EPO mRNA CTD PMID:18247414 nitric oxide decreases response to substance ISO RGD:2559 6480464 EPO protein results in decreased susceptibility to Nitric Oxide CTD PMID:15816862 nitrites increases abundance EXP 6480464 EPO protein results in increased abundance of Nitrites CTD PMID:23384249 nitrites multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [EPO protein results in increased abundance of Nitrites] CTD PMID:23384249 nitrofen decreases expression ISO RGD:2559 6480464 nitrofen results in decreased expression of EPO mRNA, nitrofen results in decreased expression of EPO protein CTD PMID:27880037 nitroprusside multiple interactions EXP 6480464 Nitroprusside inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:11286986 Nonidet P-40 decreases expression EXP 6480464 Nonidet P-40 results in decreased expression of EPO mRNA CTD PMID:26552463 ochratoxin A affects expression EXP 6480464 ochratoxin A affects the expression of EPO mRNA CTD PMID:30876885 ozone increases expression EXP 6480464 Ozone results in increased expression of EPO mRNA CTD PMID:27206323 paclitaxel decreases response to substance EXP 6480464 EPO protein results in decreased susceptibility to Paclitaxel CTD PMID:17010629 paracetamol increases expression ISO RGD:10531 6480464 Acetaminophen results in increased expression of EPO mRNA CTD PMID:22610607 paraquat multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [SOD2 gene mutant form results in increased susceptibility to Paraquat] CTD PMID:16288465 phenobarbital increases expression ISO RGD:10531 6480464 Phenobarbital results in increased expression of EPO mRNA CTD PMID:23528251 phenylhydrazine increases expression ISO RGD:2559 6480464 phenylhydrazine results in increased expression of EPO mRNA CTD PMID:22908232 pirinixic acid multiple interactions ISO RGD:10531 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of EPO mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:10531 6480464 pirinixic acid results in decreased expression of EPO mRNA CTD PMID:17950772 pyrogallol decreases expression ISO RGD:2559 6480464 Pyrogallol results in decreased expression of EPO protein CTD PMID:9927288 quercetin increases expression EXP 6480464 Quercetin results in increased expression of EPO mRNA CTD PMID:19729006 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of EPO mRNA CTD PMID:21632981 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA] more ... CTD PMID:21915944 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of EPO mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [Doxorubicin results in increased abundance of Reactive Oxygen Species] CTD PMID:17928571 reactive oxygen species decreases abundance EXP 6480464 EPO protein results in decreased abundance of Reactive Oxygen Species CTD PMID:12200812 reactive oxygen species multiple interactions ISO RGD:2559 6480464 Deferoxamine inhibits the reaction [Reactive Oxygen Species results in decreased expression of EPO protein], tetramethylthiourea inhibits the reaction [Reactive Oxygen Species results in decreased expression of EPO protein] CTD PMID:9927288 resveratrol multiple interactions EXP 6480464 resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with C5 protein] results in increased secretion of EPO protein], resveratrol analog inhibits the reaction [[Cytochalasin B co-treated with IL5 protein] results in increased secretion of EPO protein] CTD PMID:18776917 ribavirin multiple interactions EXP 6480464 [peginterferon alfa-2b co-treated with Ribavirin] affects the expression of EPO protein, [Ribavirin co-treated with Interferons] results in increased expression of EPO protein CTD PMID:15232364 , PMID:20009130 ribavirin increases expression EXP 6480464 Ribavirin results in increased expression of EPO CTD PMID:12713065 salubrinal multiple interactions EXP 6480464 [salubrinal co-treated with EPO protein] results in decreased expression of ATF4 protein, [salubrinal co-treated with EPO protein] results in increased phosphorylation of EIF2S1 protein CTD PMID:23690448 sapropterin increases abundance ISO RGD:10531 6480464 EPO protein results in increased abundance of sapropterin CTD PMID:25490417 sapropterin multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [[GCH1 gene mutant form results in increased oxidation of sapropterin] which results in increased chemical synthesis of 7 more ... CTD PMID:25041251 , PMID:25490417 sapropterin multiple interactions EXP 6480464 EPO protein inhibits the reaction [GCH1 mutant form results in decreased abundance of sapropterin] CTD PMID:25041251 simvastatin multiple interactions ISO RGD:2559 6480464 Simvastatin inhibits the reaction [Streptozocin results in decreased expression of EPO protein], Simvastatin inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] CTD PMID:20821229 sodium stibogluconate decreases expression EXP 6480464 Antimony Sodium Gluconate results in decreased expression of EPO mRNA, Antimony Sodium Gluconate results in decreased expression of EPO protein CTD PMID:9531339 staurosporine decreases response to substance ISO RGD:2559 6480464 EPO protein results in decreased susceptibility to Staurosporine CTD PMID:15816862 staurosporine multiple interactions ISO RGD:2559 6480464 tin mesoporphyrin inhibits the reaction [EPO protein results in decreased susceptibility to Staurosporine] CTD PMID:15816862 streptozocin multiple interactions ISO RGD:2559 6480464 Enalapril inhibits the reaction [Streptozocin results in increased expression of EPO mRNA] more ... CTD PMID:19958114 , PMID:20821229 streptozocin increases expression ISO RGD:2559 6480464 Streptozocin results in increased expression of EPO mRNA CTD PMID:19958114 , PMID:20821229 streptozocin decreases expression ISO RGD:2559 6480464 Streptozocin results in decreased expression of EPO protein CTD PMID:20821229 superoxide multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [[NOS3 protein co-treated with sapropterin deficiency] results in increased chemical synthesis of Superoxides] CTD PMID:25490417 testosterone multiple interactions EXP 6480464 [Dehydroepiandrosterone co-treated with Testosterone co-treated with GH1] results in decreased expression of EPO protein CTD PMID:15161484 triptonide decreases expression ISO RGD:10531 6480464 triptonide results in decreased expression of EPO mRNA CTD PMID:33045310 urethane decreases expression EXP 6480464 Urethane results in decreased expression of EPO mRNA CTD PMID:28818685 zidovudine increases expression EXP 6480464 Zidovudine results in increased expression of EPO protein CTD PMID:3422548 zidovudine multiple interactions ISO RGD:10531 6480464 EPO protein inhibits the reaction [Zidovudine results in decreased expression of EPOR mRNA] more ... CTD PMID:7646543 , PMID:9735323 zidovudine increases expression ISO RGD:10531 6480464 Zidovudine results in increased expression of EPO protein CTD PMID:1549625 , PMID:1889487 zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of EPO protein], zinc chloride inhibits the reaction [Oxygen deficiency results in increased expression of EPO mRNA] CTD PMID:11090055